Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Bailey SR et al. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets. 2000 Res. Vet. Sci. pmid:10756136
Cijevschi I and Cijevschi D [Ocular immunopathological characteristics and the involvement of the platelet-aggregation factor and the anti-PAF at the level of the eye]. 1999 Jan-Jun Rev Med Chir Soc Med Nat Iasi pmid:10756889
Liao CH et al. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets. 2000 J. Pharm. Pharmacol. pmid:10757426
Kalia N et al. Mechanisms of Helicobacter pylori-induced rat gastric mucosal microcirculatory disturbances in vivo. 2000 Dig. Dis. Sci. pmid:10759248
Triggiani M et al. Metabolism of lipid mediators in human eosinophils. 2000 Chem. Immunol. pmid:10761306
Emerson M et al. Characterization and functional significance of calcium transients in the 2-cell mouse embryo induced by an autocrine growth factor. 2000 J. Biol. Chem. pmid:10764773
Munakata M et al. Nafamostat mesilate modulates the release of platelet-activating factor during left ventricular assistance with hemofiltration in canine heart failure. 2000 Jpn. J. Thorac. Cardiovasc. Surg. pmid:10769990
Connolly AB and Vernon DR Manipulations of the metabolic response for management of patients with severe surgical illness: review. 2000 World J Surg pmid:10773122
Bastos da Silva M et al. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation. 2000 Mar-Apr Vet. Res. pmid:10779205
Lagente V et al. Effects of the platelet activating factor antagonists BN 52021 and BN 50730 on antigen-induced bronchial hyperresponsiveness and eosinophil infiltration in lung from sensitized guinea-pigs. 1993 Clin. Exp. Allergy pmid:10779293
Sehmi R et al. Interleukin-8 is a chemo-attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects. 1993 Clin. Exp. Allergy pmid:10779297
Shute J Signal transduction mechanisms in human eosinophils. 1993 Clin. Exp. Allergy pmid:10779300
Hauser CJ et al. Major trauma enhances store-operated calcium influx in human neutrophils. 2000 J Trauma pmid:10780589
Yamada Y et al. Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population. 2000 Atherosclerosis pmid:10781653
Smith J et al. Differences in gene density on chicken macrochromosomes and microchromosomes. 2000 Anim. Genet. pmid:10782207
Friedman E et al. Effect of hydrocortisone on platelet activating factor induced lung edema in isolated rabbit lungs. 2000 Respir Physiol pmid:10786645
Asai Y et al. A temperature study on critical micellization concentration of the novel platelet-activating factor receptor antagonist E5880 in water by electric conductivity measurements. 2000 Drug Dev Ind Pharm pmid:10789068
Oshiro T et al. Characterization of platelet-activating factor-induced cytosolic calcium mobilization in human eosinophils. 2000 Clin. Exp. Allergy pmid:10792362
Asai Y and Watanabe S Characterization of the physicochemical properties of the micelles by the novel platelet activating factor receptor antagonist E5880. 2000 Eur J Pharm Biopharm pmid:10799812
Balsinde J et al. Cellular regulation of cytosolic group IV phospholipase A2 by phosphatidylinositol bisphosphate levels. 2000 J. Immunol. pmid:10799904
Dearn S et al. Activation of platelet-activating factor (PAF) receptor stimulates nitric oxide (NO) release via protein kinase C-alpha in HEC-1B human endometrial epithelial cell line. 2000 Mol. Med. pmid:10803407
Kosaka T et al. Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity. 2000 Clin. Chim. Acta pmid:10807978
Kulikov VI and Muzya GI Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation. 2000 Biochemistry Mosc. pmid:10810178
Shindou H et al. Roles of cytosolic phospholipase A(2) and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. 2000 Biochem. Biophys. Res. Commun. pmid:10814544
Luu NT et al. Differential ability of exogenous chemotactic agents to disrupt transendothelial migration of flowing neutrophils. 2000 J. Immunol. pmid:10820279
Sugatani J et al. Inhibition of rabbit platelet aggregation by nucleoside 5'-alkylphosphates: correlation with inhibition of agonist-induced calcium influx. 2000 Biochem. Pharmacol. pmid:10825464
Ohishi S [Evaluation of time course and inter-relationship of inflammatory mediators in experimental inflammatory reaction]. 2000 Yakugaku Zasshi pmid:10825809
Asai Y et al. Characterization of the physicochemical properties of the micelles of platelet-activating factor (C18:0). 2000 Drug Dev Ind Pharm pmid:10826115
Tokumura A et al. Structural identification of phosphatidylcholines having an oxidatively shortened linoleate residue generated through its oxygenation with soybean or rabbit reticulocyte lipoxygenase. 2000 J. Lipid Res. pmid:10828088
Mizutani Y et al. Cloning and expression of rat neutral sphingomyelinase: enzymological characterization and identification of essential histidine residues. 2000 Biochim. Biophys. Acta pmid:10832103
Serradji N et al. Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication. 2000 J. Med. Chem. pmid:10841793
Ma X and Bazan HE Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing. 2000 Invest. Ophthalmol. Vis. Sci. pmid:10845588
Kobayashi N et al. Transepithelial migration of activated eosinophils induces a decrease of E-cadherin expression in cultured human nasal epithelial cells. 2000 Clin. Exp. Allergy pmid:10848899
Poveshchenko AF and Kozlov VA [The effect of platelet-activating factor and its antagonist--BN 52021--on immune reactions in vivo in mice and in vitro]. 1999 Jul-Aug Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:10852052
Fukuyama S et al. Effect of eotaxin and platelet-activating factor on airway inflammation and hyperresponsiveness in guinea pigs in vivo. 2000 Am. J. Respir. Crit. Care Med. pmid:10852755
Zhu X et al. A surrogate method for assessment of beta(2)-integrin-dependent adhesion of human eosinophils to ICAM-1. 2000 J. Immunol. Methods pmid:10854610
Caslake MJ et al. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. 2000 Atherosclerosis pmid:10856534
Nakajima T et al. Phospholipase A2-mediated superoxide production of murine peritoneal macrophages induced by chrysotile stimulation. 2000 Int. J. Biochem. Cell Biol. pmid:10856708
Denizot Y et al. Effect of cytokines and lipid mediators on the synthesis of interleukin 1 beta by human bone marrow stromal cells. 2000 Cytokine pmid:10857767
Huo LJ and Yang ZM Effects of platelet activating factor on capacitation and acrosome reaction in mouse spermatozoa. 2000 Mol. Reprod. Dev. pmid:10862011
Cavallo-Perin P et al. Increased blood levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria. 2000 Nephrol. Dial. Transplant. pmid:10862637
Bae K et al. Platelet-activating factor (PAF)-dependent transacetylase and its relationship with PAF acetylhydrolases. 2000 J. Biol. Chem. pmid:10867005
Alappatt C et al. Acute keratinocyte damage stimulates platelet-activating factor production. 2000 Arch. Dermatol. Res. pmid:10867814
Suzuki S et al. The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion. 2000 Transplantation pmid:10868624
Xu H et al. Platelet-activating factor acetylhydrolase gene mutation in Japanese children with Escherichia coli O157-associated hemolytic uremic syndrome. 2000 Am. J. Kidney Dis. pmid:10873870
Viswanath M et al. Reduction of hypoxic-ischemic brain swelling in the neonatal rat with PAF antagonist WEB 2170: lack of long-term protection. 2000 Pediatr. Res. pmid:10879808
Kusuhara H et al. Y-24180, an antagonist of platelet-activating factor, suppresses interleukin 5 production in cultured murine th(2)cells and human peripheral blood mononuclear cells. 2000 Cytokine pmid:10880261
Tektonidou MG et al. Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestations. 2000 Eur. J. Clin. Invest. pmid:10886305
Aihara M et al. Interaction between neurone and microglia mediated by platelet-activating factor. 2000 Genes Cells pmid:10886367
Dent G et al. Involvement of protein tyrosine kinases in activation of human eosinophils by platelet-activating factor. 2000 Immunology pmid:10886400
Folch E et al. H(2)O(2) and PARS mediate lung P-selectin upregulation in acute pancreatitis. 2000 Free Radic. Biol. Med. pmid:10889459
Bailey SR et al. Differential activation of platelets from normal and allergic ponies by PAF and ADP. 2000 Inflamm. Res. pmid:10893045
Lee YM et al. Platelet-activating factor contributes to acute lung leak in rats given interleukin-1 intratracheally. 2000 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:10893205
Rose F et al. E. coli hemolysin-induced lipid mediator metabolism in alveolar macrophages: impact of eicosapentaenoic acid. 2000 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:10893208
Hu L et al. Alkyl and alkoxycarbonyl derivatives of ginkgolide B: synthesis and biological evaluation of PAF inhibitory activity. 2000 Bioorg. Med. Chem. pmid:10896127
Parkman HP et al. The contractile action of platelet-activating factor on gallbladder smooth muscle. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:10898747
Clark GD et al. Neuronal platelet-activating factor receptor signal transduction involves a pertussis toxin-sensitive G-protein. 2000 Neurochem. Res. pmid:10905621
Wang JH and Sun GY Platelet activating factor (PAF) antagonists on cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC). 2000 Neurochem. Res. pmid:10905622
Baker RR Lipid acetylation reactions and the metabolism of platelet-activating factor. 2000 Neurochem. Res. pmid:10905630
Francescangeli E et al. Properties and regulation of microsomal PAF-synthesizing enzymes in rat brain cortex. 2000 Neurochem. Res. pmid:10905633
Parrish PR and Larson DF Pharmacological effect of nitroprusside on platelet aggregation. 1999 J Extra Corpor Technol pmid:10915472
Unno N et al. Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in japan. 2000 J. Vasc. Surg. pmid:10917985
Hu GL and Guo HS [Progress in platelet-activating factor receptor research]. 1997 Sheng Li Ke Xue Jin Zhan pmid:10921090
Choi JH et al. Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-kappaB. 2000 Inflammation pmid:10921504
Smalley DM et al. The local effect of PAF on leukocyte adherence to small bowel mesenteric venules following intra-abdominal contamination. 2000 Inflammation pmid:10921505
O'Brien JG et al. Effects of tranexamic acid and aprotinin, two antifibrinolytic drugs, on PAF-induced plasma extravasation in unanesthetized rats. 2000 Inflammation pmid:10921506
Klyubin IV et al. The role of reactive oxygen species in membrane potential changes in macrophages and astrocytes. 2000 Membr Cell Biol pmid:10926373
Roudebush WE and Purnell ET Platelet-activating factor content in human spermatozoa and pregnancy outcome. 2000 Fertil. Steril. pmid:10927041
Matsunaga Y et al. Regulation of lymphocyte proliferation by eosinophils via chymotrypsin-like protease activity and adhesion molecule interaction. 2000 Br. J. Pharmacol. pmid:10928955
Capasso R et al. Preventive effect of eugenol on PAF and ethanol-induced gastric mucosal damage. 2000 Fitoterapia pmid:10930724
Henig NR et al. Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses. 2000 Am. J. Respir. Crit. Care Med. pmid:10934081
Haribabu B et al. Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. 2000 J. Exp. Med. pmid:10934231
Miyatake T et al. Analysis of cardiac function during hyperacute rejection: effects of PAF antagonist, TXA(2) inhibitor/antagonists, and nitroglycerin. 2000 Transplant. Proc. pmid:10936319
Raible DG et al. Hydrogen peroxide release from human eosinophils on fibronectin: scopoletin enhances eosinophil activation. 2000 Free Radic. Biol. Med. pmid:10938462
Baskova I et al. Inhibition of induced and spontaneous platelet aggregation by destabilase from medicinal leech. 2000 Platelets pmid:10938885
Pávó I et al. Interactions of pro-inflammatory and vasoactive mediators with nitric oxide in the regulation of rat vascular permeability during laparotomy. 2000 Eur. J. Pharmacol. pmid:10940373
Balestrieri ML and Lee T Regulation of the biosynthesis of acyl analogs of platelet-activating factor by purinergic agonist in endothlial cells. 2000 FEBS Lett. pmid:10940389
Porta C et al. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF. 2000 Haematologica pmid:10942928
Miyao Y et al. Role of cytokines and adhesion molecules in ischemia and reperfusion in patients with acute myocardial infarction. 1999 Jpn. Circ. J. pmid:10943615
Kobayashi Y et al. [Inhibitory effect of suplatast tosilate on eosinophil migration]. 2000 Arerugi pmid:10944827
Liu JK et al. Paeonilide, a novel anti-PAF-active monoterpenoid-derived metabolite from Paeonia delavayi. 2000 Biosci. Biotechnol. Biochem. pmid:10945272
Ueda T et al. Pancreatitis-associated ascitic fluid increases intracellular Ca(2+) concentration on hepatocytes. 2000 J. Surg. Res. pmid:10945960
Marathe GK et al. Bioactive phospholipid oxidation products. 2000 Free Radic. Biol. Med. pmid:10946218
Zhuang Q et al. Activation via multiple signaling pathways induces down-regulation of platelet-activating factor receptors on human B lymphocytes. 2000 J. Immunol. pmid:10946267
Davenpeck KL et al. Activation of human leukocytes reduces surface P-selectin glycoprotein ligand-1 (PSGL-1, CD162) and adhesion to P-selectin in vitro. 2000 J. Immunol. pmid:10946308
Martin M et al. [Antiretroviral ant anti-inflammatory properties of a novel platelet activation factor antagonist, PMS-601]. 2000 Pathol. Biol. pmid:10949851
Countryman NB et al. Evidence for involvement of the epidermal platelet-activating factor receptor in ultraviolet-B-radiation-induced interleukin-8 production. 2000 J. Invest. Dermatol. pmid:10951245
Soeki T et al. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction. 2000 Jpn. Circ. J. pmid:10952148
Gálvez J et al. Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat. 2000 Br. J. Pharmacol. pmid:10952687
Maniscalco M et al. The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide. 2000 Allergy pmid:10955702
Oktar BK et al. Endothelin-1-induced PMN infiltration and mucosal dysfunction in the rat small intestine. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:10960346
Jeon SY et al. Ultrastructural changes in platelet activating factor-induced epithelial damage in rabbit maxillary sinus mucosa. 2000 Ann. Otol. Rhinol. Laryngol. pmid:10961804
Toró A et al. Transannular Diels-Alder studies on the asymmetric total synthesis of chatancin: the pyranophane approach. 2000 Org. Lett. pmid:10964353
Durán WN et al. Stimulation of NO production and of eNOS phosphorylation in the microcirculation in vivo. 2000 Microvasc. Res. pmid:10964584
Wereszczynska-Siemiatkowska U et al. Lysosomal activity of pulmonary alveolar macrophages in acute experimental pancreatitis in rats with reference to positive PAF-antagonist (BN 52021) effect. 2000 Exp. Toxicol. Pathol. pmid:10965985
Prescott SM et al. Platelet-activating factor and related lipid mediators. 2000 Annu. Rev. Biochem. pmid:10966465
Kim JD et al. Platelet activating factor acetylhydrolase decreases lung reperfusion injury. 2000 Ann. Thorac. Surg. pmid:10969656
Taguchi R et al. Two-dimensional analysis of phospholipids by capillary liquid chromatography/electrospray ionization mass spectrometry. 2000 J Mass Spectrom pmid:10972995
Saito S et al. Modulatory roles of RANTES in IL-4 production by human blood CD4(+)T cells. 2000 Cytokine pmid:10975998
Tanaka R et al. Genetics of immunoglobulin A nephropathy. 2000 Ann. Acad. Med. Singap. pmid:10976391